Food effect on meal administration time of pharmacokinetic profile of cilostazol, a BCS class II drug-Reference-Cited by-同舟云学术

Food effect on meal administration time of pharmacokinetic profile of cilostazol, a BCS class II drug

Published:2019-05-02 Issue:2 Volume:50 Page:232-236
ISSN:0049-8254
Container-title:Xenobiotica
language:en
Short-container-title:Xenobiotica

Author:

Miyake Masateru¹²,Oka Yoshikazu¹,Mukai Tadashi¹

Affiliation:

1. Bioavailability Research Project Formulation Research Institute, Otsuka Pharmaceutical Co. Ltd., Tokushima, Japan;

2. Quality Assurance Department, Quality Assurance Section, Headquarters for Product Safety and Quality Assurance, Otsuka Pharmaceutical Co. Ltd., Tokushima, Japan

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00498254.2019.1602746

Reference21 articles.

1. Relative Bioavailability and Effects of a High Fat Meal on Single Dose Cilostazol Pharmacokinetics

2. Cilostazol stroke prevention study: A placebo-controlled double-blind trial for secondary prevention of cerebral infarction

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Vitro/In Vivo Correlation of Two Extended-Release Cilostazol Formulations;Pharmaceuticals;2024-06-16

2. Pharmacokinetic and Safety Comparison of Fixed‐Dose Combination of Cilostazol/Rosuvastatin (200 + 20 mg) Versus Concurrent Administration of the Separate Components in Healthy Adults;Clinical Pharmacology in Drug Development;2024-03-12

3. A first-in-human phase 1 study of simnotrelvir, a 3CL-like protease inhibitor for treatment of COVID-19, in healthy adult subjects;European Journal of Pharmaceutical Sciences;2023-12

4. DEVELOPMENT AND ASSESSMENT OF THE CILOSTAZOL SOLID DISPERSION EMPLOYING MELT AND SOLVENT EVAPORATION METHOD AND ITS COMPARISON;International Journal of Applied Pharmaceutics;2023-11-07

5. Physiologically based absorption modeling to predict the bioequivalence of two cilostazol formulations;Clinical and Translational Science;2023-09-25